<DOC>
	<DOCNO>NCT00481975</DOCNO>
	<brief_summary>The primary objective ass effect rimonabant compare placebo weight loss period 6 month prescribe mild hypocaloric diet obese patient binge eat disorder . The secondary objective : - ass effect rimonabant number binge episode per week , assess effect rimonabant eat behavior use Binge Eating Scale ( BES ) Three Factor Eating Questionnaire ( TFEQ ) , - evaluate safety tolerability rimonabant period 6 month .</brief_summary>
	<brief_title>Efficacy Safety Rimonabant Weight Loss Frequency Binge Episodes Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Body Mass Index ( BMI ) ≥30 ≤45 kg/m² Diagnosis eat disorder use The Questionnaire Eating Weight Patterns ( QEWPR ) diagnose Eating Behaviors History surgical procedure weight loss Treatment antiobesity drug within 3 month prior screen visit Presence history Diagnostic Statistical Manual Mental Disorders ( 4th edition ) ( DSM IV ) bulimia anorexia nervosa The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>binge eat</keyword>
	<keyword>eat disorder</keyword>
	<keyword>obesity</keyword>
</DOC>